Vitamin-based life-extention therapy for Males: ATRA (a derivative of Vitamin-A) increases male longevity via up regulation of its target gene, 20/October/2014, 6.08 am

Physiological and Pathological mechanisms that control glycolysis: NR2F2 inhibits glycolysis and cancer progression via down regulation of PDK1, 20/October/2014, 6.03 am
October 20, 2014
MiRNA-based therapy for Alzhemer’s disease and tauopathies: MiRNA-520c decreases tau phosphorylation and ameliorates tau pathology via down regulation of its target gene, 20/October/2014, 6.13 am
October 20, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, L., Vitamin-based life-extention therapy for Males: ATRA (a derivative of Vitamin-A) increases male longevity via up regulation of its target gene, 20/October/2014, 6.08 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Significance:  Numerous studies show that ATRA has health benefits. This study suggests, for the first time,  that ATRA, by increasing the expression of its target gene, it may increase longevity. Thus, pharmacological formulations encompassing “ATRA or its analogues” can be used to increase  the life expectancy of Males.

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Comments are closed.